3 Healthcare IPOs to Watch This Month
Sotera Health, Maravai Life Sciences, and Olema Pharmaceuticals (NASDAQ:OLMA) are all filing IPOs as "emerging growth companies" as defined by the 2012 Jumpstart Our Business Startups Act, which gives them extra time to comply with the accounting standards that are expected of public companies. That means you have to dig a little bit deeper to see if these are worthwhile IPOs.
All three are going public to raise money to allow their companies to grow. And all three lost money last year. Sotera, which plans to trade on the Nasdaq with the symbol SHC, said it plans to sell 46.6 million shares between $20 and $23 each, which would bring in a little more than $1 billion.
Maravai, which will trade on the NASDAQ with the ticker MRVI, said it estimates its IPO's price per share will be between $24 and $27, with the company planning to sell 50 million shares, raising roughly $1.3 billion. Olema said it plans to sell 11 million shares with the IPO price at $19 per share, bringing it potentially $190 million.
Source Fool.com
